Virus Filtration Market Growth and Analysis To 2025 By Top Players
Virus
filtration is a robust and effective virus clearance technology that is common
unit operation in the manufacture of biologics. Some biological therapeutic
products are produced using mammalian cell lines or human plasma. The risk of
contamination with either known or unknown viruses in these products has been
demonstrated; hence, regulatory agencies have mandated that manufacturers
evaluate the risks of virus contamination and take necessary measures to
mitigate these risks.
Key factors
driving the market are rapid growth of pharmaceutical and biotechnology
industry, increasing investments in R&D and outsourcing activities are key
drivers for the growth of the market. The report would be of an interest to
various stakeholders operating in the virus filtration market. These
stakeholders include healthcare institutes, contract research organizations
(CROs), research institutes, virus filtration product manufacturers and
vendors, research consulting firms, virus filtration service providers,
distributors and others.
The major
players operating in the market include Merck KGaA, Sartorius AG, Thermo Fisher
Scientific Inc., Danaher (Pall Corporation), General Electric, Lonza, Charles
River, Asahi Kasei Medical Co., Ltd., Wuxi AppTec, and Clean Cells among others.
![]() |
| Virus Filtration |

Comments
Post a Comment